Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InMed Pharmaceuticals (INM) Current Leases: 2022-2025

Historic Current Leases for InMed Pharmaceuticals (INM) over the last 4 years, with Jun 2025 value amounting to $435,507.

  • InMed Pharmaceuticals' Current Leases rose 0.12% to $424,765 in Q3 2025 from the same period last year, while for Sep 2025 it was $424,765, marking a year-over-year increase of 0.12%. This contributed to the annual value of $435,507 for FY2025, which is 37.04% up from last year.
  • InMed Pharmaceuticals' Current Leases amounted to $435,507 in FY2025, which was up 37.04% from $317,797 recorded in FY2024.
  • In the past 5 years, InMed Pharmaceuticals' Current Leases ranged from a high of $435,507 in FY2025 and a low of $317,797 during FY2024.
  • Over the past 3 years, InMed Pharmaceuticals' median Current Leases value was $375,713 (recorded in 2023), while the average stood at $376,339.
  • As far as peak fluctuations go, InMed Pharmaceuticals' Current Leases decreased by 15.41% in 2024, and later surged by 37.04% in 2025.
  • InMed Pharmaceuticals' Current Leases (Yearly) stood at $404,276 in 2022, then fell by 7.07% to $375,713 in 2023, then declined by 15.41% to $317,797 in 2024, then spiked by 37.04% to $435,507 in 2025.